Document Detail


Personalised Medicine and Asthma Diagnostics/Management.
MedLine Citation:
PMID:  23212666     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Human beings come in all shapes and sizes. Heterogeneity makes life interesting, but leads to inter-individual variation in disease susceptibility and response to therapy. One major health challenge is to develop "personalised medicine"; therapeutic interventions tailored to an individual to ensure optimal treatment of disease. Asthma is a heterogeneous disease with several different phenotypes triggered by multiple gene-environment interactions. Inhaled corticosteroids and β2-agonists have been the mainstay asthma therapies for 30 years, but they are not effective in all patients, while high costs and side-effects also drive the need for better targeted treatment of asthma. Pharmacogenetics is the study of variations in the genetic code for proteins in signaling pathways targeted by pharmacological therapies. Biomarkers are biological markers obtained from patients that can aid in asthma diagnosis, prediction of treatment response, and monitoring of disease control. This review presents a broad discussion of the use of genetic profiling and biomarkers to better diagnose, monitor, and tailor the treatment of asthmatics. We also discuss possible future developments in personalised medicine, including the construction of artificially engineered airway tissues containing a patient's own cells for use as personalised drug-testing tools.
Authors:
Samuel J Wadsworth; Andrew J Sandford
Related Documents :
21151566 - Cystatin c: a candidate biomarker for amyotrophic lateral sclerosis.
24255846 - Socio-economic impact of rift valley fever to pastoralists and agro pastoralists in aru...
21250936 - Neurogenic drugs and compounds to treat cns diseases and disorders.
23777766 - Disregulated signaling pathways in the development of cntrl-fgfr1-induced myeloid and l...
2917226 - 1h nuclear magnetic resonance investigation of synovial fluid components in osteoarthri...
15324736 - A common pathway in periodic fever syndromes.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-5
Journal Detail:
Title:  Current allergy and asthma reports     Volume:  -     ISSN:  1534-6315     ISO Abbreviation:  Curr Allergy Asthma Rep     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101096440     Medline TA:  Curr Allergy Asthma Rep     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
UBC James Hogg Research Centre, Institute for Heart and Lung Health, St Paul's Hospital, 166-1081 Burrard St, Vancouver, British Columbia, Canada, V6Z 1Y6, Samuel.Wadsworth@hli.ubc.ca.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of tamoxifen, methoxyprogesterone acetate and combined treatment on cellular proliferation an...
Next Document:  Immunology and clinical manifestations of non-clonal mast cell activation syndrome.